Insights in Clinical and Translational Physiology: 2023

We are now in the third decade of the 21st Century, and the achievements made by scientists, especially in recent years, have been exceptional, leading to major advancements in the fast-growing field of Clinical and Translational Physiology. Frontiers has organized a series of Research Topics to highlight the latest scientific advancements in order to be at the forefront of science in different fields of research. This editorial initiative of particular relevance, led by the Specialty Chief Editor Johannes van Lieshout and Associate Editors Markus W. Hollmann, Gaetano Santulli and Christina Pabelick, is focused on new insights, novel developments, current challenges, latest discoveries, recent advances and future perspectives in the field of Clinical and Translational Physiology.

The Research Topic welcomes brief, forward-looking contributions from members of the editorial board that describe the state of the art, and outline recent developments and major accomplishments that have been achieved and need to occur to move the field forward. Authors are encouraged to identify the greatest challenges in the sub-disciplines, and how to address those challenges.

The goal of this collection is to shed light on the progress made in the past decade and future challenges to provide a thorough overview of the status of the Physiology field. This Research Topic will inspire, inform and provide direction and guidance to researchers in the field.

Given the success of Insights in Clinical and Translational Physiology: 2022 and the continuing advances in the field, we are pleased to announce the 2023 edition.

Keywords: Clinical Physiology, Translational Physiology, Advances, Future Developments

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.